Package 65219-534-10

{"route": ["INTRAVENOUS"], "spl_id": "63b55787-c021-4399-b16f-a445eaeb8e5b", "openfda": {"nui": ["N0000175634", "N0000175632"], "unii": ["6T84R30KC1"], "rxcui": ["2170286"], "spl_set_id": ["63f6c65f-b06b-4905-8ff8-3ac87569c7e0"], "pharm_class_pe": ["Decreased Fibrinolysis [PE]"], "pharm_class_epc": ["Antifibrinolytic Agent [EPC]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "24 BAG in 1 CASE (65219-534-10)  / 100 mL in 1 BAG (65219-534-01)", "package_ndc": "65219-534-10", "marketing_start_date": "20241201"}], "brand_name": "TRANEXAMIC ACID IN SODIUM CHLORIDE", "product_id": "65219-534_63b55787-c021-4399-b16f-a445eaeb8e5b", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antifibrinolytic Agent [EPC]", "Decreased Fibrinolysis [PE]"], "product_ndc": "65219-534", "generic_name": "tranexamic acid", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TRANEXAMIC ACID IN SODIUM CHLORIDE", "active_ingredients": [{"name": "TRANEXAMIC ACID", "strength": "10 mg/mL"}], "application_number": "ANDA218242", "marketing_category": "ANDA", "marketing_start_date": "20241201", "listing_expiration_date": "20261231"}